Biblio
2024
Shapiro RM, Kim HT, Duléry R, Liney D, Garrity HM, Panaro KM, Au C, Gervais C, Little JS, Ho VT, et al. Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor survival. Blood Adv. 2024.